Credit Suisse’s Allergan Inc AGN Stock Holding History

Credit Suisse’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,317,143	Closed	-$280M	–	4856
2014 Q4	$280M	Buy	1,317,143 +158,479	+14%	+$31.5M	0.25%	74
2014 Q3	$206M	Sell	1,158,664 -255,537	-18%	-$42.4M	0.17%	107
2014 Q2	$239M	Buy	1,414,201 +251,618	+22%	+$39.2M	0.2%	95
2014 Q1	$144M	Buy	1,162,583 +7,752	+0.7%	+$944K	0.14%	123
2013 Q4	$128M	Buy	1,154,831 +99,334	+9%	+$9.49M	0.12%	150
2013 Q3	$95.5M	Sell	1,055,497 -172,174	-14%	-$15.5M	0.1%	189
2013 Q2	$103M	Buy	+1,227,671	New	+$127M	0.1%	170

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Credit Suisse's AGN Position: Q1 2015 in Review

Credit Suisse sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,317,143 shares — an estimated $280M sold.

Credit Suisse first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $280M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Credit Suisse reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Credit Suisse sold 1,317,143 Allergan Inc shares in Q1 2015, an estimated $280M.
Credit Suisse first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Credit Suisse's Allergan Inc position peaked at $280M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.